Announcements Trials
Browse Landscape

Phase

Phase 1 2Phase 3 1Phase 2 1

Status

Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Leukemia 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Lymphoma, Large B-Cell, Diffuse 2Lymphoma 2Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Lymphoma, Non-Hodgkin 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Follicular 1Lung Neoplasms 1Leukemia, Myelomonocytic, Acute 1Leukemia, Myeloid, Acute 1Leukemia, Monocytic, Acute 1Leukemia, Megakaryoblastic, Acute 1Leukemia, Erythroblastic, Acute 1Ependymoma 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1

Interventions

Vincristine 5Ifosfamide 5Etoposide 5Radiotherapy 4Doxorubicin 4Cyclophosphamide 4Dactinomycin 3Neoadjuvant Therapy 2Chemotherapy, Adjuvant 2Brachytherapy 2etoposide phosphate 1Topotecan 1Temozolomide 1Mesna 1Melphalan 1Irinotecan 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1Fentanyl 1FANG vaccine 1Epirubicin 1Dexrazoxane 1Cyproheptadine 1Carboplatin 1Busulfan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 3 × Neuroectodermal Tumors, Primitive, Peripheral × Mesna × Clear all
NCT00002516 2013-09-17

Combination Chemotherapy Plus Surgery and Radiation Therapy in Treating Patients With Ewing's Sarcoma

National Cancer Institute (NCI)

Phase 3 Unknown
Sarcoma

Sarcoma, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡